Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct;1(4):216-9.
doi: 10.4103/0974-7788.76784.

Efficacy and safety of livwin (polyherbal formulation) in patients with acute viral hepatitis: A randomized double-blind placebo-controlled clinical trial

Yogendra Keche  1 , Vandana Badar, Mrunalini Hardas
Affiliations

Efficacy and safety of livwin (polyherbal formulation) in patients with acute viral hepatitis: A randomized double-blind placebo-controlled clinical trial

Yogendra Keche et al. Int J Ayurveda Res. 2010 Oct.

Abstract

Objectives: The study was planned to evaluate the efficacy and safety of Livwin (polyherbal formulation) in acute viral hepatitis.

Materials and methods: In this study, there were 29 patients in each group, receiving either Livwin (containing Ashwagandha, Arjuna, Bhumyamalaki, Daruharidra, Guduchi, Kutki and Punarnava) or placebo capsules containing lactose powder (500 mg). Both drugs were given orally two capsules two times a day for eight weeks followed by treatment free period of four weeks. Recovery of patients was assessed by noting symptomatic recovery and by measuring levels of serum bilirubin, serum aspartate aminotransferase (AST), serum alanine aminotransferase (ALT), alkaline phosphatase at baseline, 2, 4, 8 and 12 weeks.

Results: Significant earlier recovery of weakness was observed with Livwin as compared to placebo at 2, 4 and 8 weeks. Serum bilirubin and ALT was observed in normal range in significantly more number of patients with Livwin treatment as compared to placebo at 2, 4 and 8 weeks. AST was observed in normal range in significantly more number of patients with Livwin treatment as compared to placebo at 2 and 4 weeks.

Conclusions: Livwin is found effective in uncomplicated patients of acute viral hepatitis. Epigastric pain and diarrhea were reported with Livwin treatment.

Keywords: Acute hepatitis; Phyllanthus niruri linn; Tinospora cordifolia (willd.) miers.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Park K. 18th ed. Jabalpur: Banarsidas Bhanot Publishers; 2005. Parks Textbook of Preventive and Social Medicine.
    1. Acharya SK, Batra Y, Hazari S, Choudhury V, Panda SK, Dattagupta S. Etiopathogenesis of acute hepatic failure: Eastern versus western countries. J Gastroenterol Hepatol. 2002;17:s268–73. - PubMed
    1. Dienstag JL, Isselbacher KJ. Harrisons Principles of Internal Medicine. In: Braunwald K, Hauser F, Longo, J, editors. Acute viral hepatitis. 16th ed. New York: Mc Graw Hill; 2005. pp. 1822–38.
    1. Kolhapure SA, Mitra SK. Meta-analysis of 50 phase III clinical trials in evaluation of efficacy and safety of Liv.52 infective hepatitis. Med update. 2004;12:51–61.
    1. Dange SV, Patki PS, Pawar SS, Phadke SA, Shrotri DS. Comparative efficacy of five indigenous compound formulations in patients of acute viral hepatitis. Maharashtra Med J. 1989;36:75–80.

LinkOut - more resources